Incidence of Vasospasm, Outcome, and Quality of Life after Endovascular and Surgical Treatment of Ruptured Intracranial Aneurysms: Results of a Single-Center Prospective Study in Switzerland
Table 4
Outcome and quality of life after surgical and endovascular occlusion of the aneurysm.
Surgical Treatment
value surgical
value CVS surgical
Endovascular treatment
Total
clinical CVS
no clinical CVS
versus endovascular
versus CVS endovascular
Total
clinical CVS
no clinical CVS
Survivors/total patients
35/41
7/12
28/29
—
—
24/25
5/6
19/19
Survivors (%)
85.4
58.3
96.6
—
—
96
83.3
100
Mortality (%)
14.6
41.6
3.4
NS
NS
4
16.7
0
mRS
NS
NS
MMSE*
NS
NS
NIHSS*
NS
NS
Barthel-Index*
NS
NS
EQ-5D (%)
*:
51.5
14.3
61.5
NS
52.2
80
44.4
Mobility (%)‡
12.1
14.3
9.1
34.8
80
22.2
Self-Care (%)‡
12.1
0
15.4
NS
21.7
60
11.1
Usual activities (%)‡
27.3
14.3
30.8
NS
39.1
80
27.8
Pain/Discomfort (%)‡
30.3
0
38.5
NS
39.1
60
33.3
Anxiety/Depression (%)‡
24.2
14.3
26.9
NS
NS
21.7
60
11.1
Patients’ health (VAS)
NS
NS
SF-12 †:
PCS
48.69
49.75
48.36
NS
NS
48.22
41.34
49.44
MCS
43.18
44.23
42.85
NS
NS
45.47
35.46
47.42
CVS: cerebral vasospasm; mRS: modified Rankin Score; MMSE: Minimental State Examination; NIHSS: National Institutes of Health Stroke Scale; NS: no statistically significant. *: measurements in survivors. EQ-5D: EuroQoL health state; VAS: visual analog scale for patients’ health state (0–100); *: patients reporting problems in at least one of the EuroQol items. ‡: patients presenting with any limitation (level 2 or 3); SF-12: Short Form-12; PCS: physical component summary; MCS: mental component summary; †: measurements based on 30 out of 35 patients in the surgical group and 20 out of 24 in the endovascular group. All data are expressed as mean ± standard deviation.
